The use of drotrecogin alfa recombinant activated prot... [Burns. 2006] - PubMed

Save items

loading

Related citations in PubMed

Review Treating severe sepsis with drotrecogin alfa (activated). [Hosp Med. 2003]
Review Treating severe sepsis with drotrecogin alfa (activated).
Wyncoll D. Hosp Med. 2003 Mar; 64(3):168-72.
Severe sepsis and the role of novel therapeutic agents. Position statement of the Critical Care Society of South Africa on severe sepsis and the role of novel therapeutic agents such as drotrecogin alfa (activated). [S Afr Med J. 2003]
Severe sepsis and the role of novel therapeutic agents. Position statement of the Critical Care Society of South Africa on severe sepsis and the role of novel therapeutic agents such as drotrecogin alfa (activated).
Critical Care Society of South Africa Working Group. S Afr Med J. 2003 Jun; 93(6):416-7.
Review The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis. [Aust Crit Care. 2003]
Review The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis.
Murgo M, Adamson H, Boyle M. Aust Crit Care. 2003 Nov; 16(4):133-43.
Use of drotrecogin alfa (activated) for severe sepsis in New Jersey acute care hospitals. [Am J Health Syst Pharm. 2006]
Use of drotrecogin alfa (activated) for severe sepsis in New Jersey acute care hospitals.
Dombrovskiy V, Martin A, Sunderram J, Paz H. Am J Health Syst Pharm. 2006 Jun 15; 63(12):1151-6.
Review Drotrecogin alfa: a new approach in the treatment of severe sepsis. [Expert Opin Biol Ther. 2002]
Review Drotrecogin alfa: a new approach in the treatment of severe sepsis.
Vincent JL. Expert Opin Biol Ther. 2002 Aug; 2(6):659-64.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

The use of drotrecogin alfa recombinant activated protein C for severe sepsis in...
The use of drotrecogin alfa recombinant activated protein C for severe sepsis in the critically burned patient: a new treatment approach.
Burns. 2006 Sep ;32(6):783-7. Epub 2006 Aug 1 .

PubMed
Neural induction in Xenopus requires inhibition of Wnt-beta-catenin signaling.
Neural induction in Xenopus requires inhibition of Wnt-beta-catenin signaling.
Dev Biol. 2006 Oct 1 ;298(1):71-86. Epub 2006 Jun 14 .

PubMed
Pharmacologic treatment of low back pain.
Pharmacologic treatment of low back pain.
Neurosurg Clin N Am. 1991 Oct ;2(4):891-7.

PubMed
The assessment and treatment of specific phobias: a review.
The assessment and treatment of specific phobias: a review.
Curr Psychiatry Rep. 2006 Aug ;8(4):298-303.

PubMed
Role of pathogenicity island-associated integrases in the genome plasticity of u...
Role of pathogenicity island-associated integrases in the genome plasticity of uropathogenic Escherichia coli strain 536.
Mol Microbiol. 2006 Aug ;61(3):584-95.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The use of drotrecogin alfa recombinant activated protein C for severe sepsis in the critically burned patient: a new treatment approach.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information